| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |